265 related articles for article (PubMed ID: 18206926)
1. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors.
Lee IH; Sadetsky N; Carroll PR; Sandler HM
J Urol; 2008 Mar; 179(3):1072-6; discussion 1076. PubMed ID: 18206926
[TBL] [Abstract][Full Text] [Related]
2. The effect of erectile function on the use of phosphodiesterase-5 inhibitors after radical prostatectomy in Japanese and U.S. men.
Namiki S; Kwan L; Kagawa-Singer M; Arai Y; Litwin MS
Urology; 2008 May; 71(5):901-5. PubMed ID: 18374396
[TBL] [Abstract][Full Text] [Related]
3. Life after radical prostatectomy: a longitudinal study.
Litwin MS; Melmed GY; Nakazon T
J Urol; 2001 Aug; 166(2):587-92. PubMed ID: 11458073
[TBL] [Abstract][Full Text] [Related]
4. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
5. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation.
Haffner MC; Landis PK; Saigal CS; Carter HB; Freedland SJ
Urology; 2005 Aug; 66(2):371-6. PubMed ID: 16040103
[TBL] [Abstract][Full Text] [Related]
7. Sexual function following radical prostatectomy: a prospective longitudinal study of cultural differences between Japanese and American men.
Namiki S; Kwan L; Kagawa-Singer M; Tochigi T; Ioritani N; Terai A; Arai Y; Litwin MS
Prostate Cancer Prostatic Dis; 2008; 11(3):298-302. PubMed ID: 17909566
[TBL] [Abstract][Full Text] [Related]
8. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
9. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
[TBL] [Abstract][Full Text] [Related]
10. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.
Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y
J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164
[TBL] [Abstract][Full Text] [Related]
11. Predictors of quality of life after radical treatment for prostate cancer.
Gacci M; Lapini A; Serni S; Livi L; Paiar F; Detti B; Simontacchi G; Vittori G; Giubilei G; Mariani M; Palli D; Carini M
Urol Int; 2008; 80(3):231-6. PubMed ID: 18480622
[TBL] [Abstract][Full Text] [Related]
12. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.
Stephenson RA; Mori M; Hsieh YC; Beer TM; Stanford JL; Gilliland FD; Hoffman RM; Potosky AL
J Urol; 2005 Aug; 174(2):646-50; discussion 650. PubMed ID: 16006930
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in young men after radical prostatectomy.
Wright JL; Lin DW; Cowan JE; Carroll PR; Litwin MS;
Prostate Cancer Prostatic Dis; 2008; 11(1):67-73. PubMed ID: 17519925
[TBL] [Abstract][Full Text] [Related]
14. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE.
Litwin MS; Sadetsky N; Pasta DJ; Lubeck DP
J Urol; 2004 Aug; 172(2):515-9. PubMed ID: 15247718
[TBL] [Abstract][Full Text] [Related]
15. Urinary and sexual quality of life 1 year following robotic assisted laparoscopic radical prostatectomy.
Shikanov SA; Eng MK; Bernstein AJ; Katz M; Zagaja GP; Shalhav AL; Zorn KC
J Urol; 2008 Aug; 180(2):663-7. PubMed ID: 18554650
[TBL] [Abstract][Full Text] [Related]
16. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.
Schiff JD; Bar-Chama N; Cesaretti J; Stock R
BJU Int; 2006 Dec; 98(6):1255-8. PubMed ID: 17125483
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
Ohebshalom M; Parker M; Guhring P; Mulhall JP
J Urol; 2005 Jul; 174(1):258-62; discussion 262. PubMed ID: 15947650
[TBL] [Abstract][Full Text] [Related]
18. Defining sexual outcomes after treatment for localized prostate carcinoma.
Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
[TBL] [Abstract][Full Text] [Related]
19. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective.
Newton FJ; Burney S; Millar JL; Frydenberg M; Ng KT
BJU Int; 2006 Jun; 97(6):1179-83. PubMed ID: 16686708
[TBL] [Abstract][Full Text] [Related]
20. Quality of life after radical prostatectomy in Japanese men: 2 year longitudinal study.
Namiki S; Saito S; Satoh M; Ishidoya S; Kawamura S; Tochigi T; Kuwahara M; Aizawa M; Ioritani N; Yoshimura K; Ichioka K; Terai A; Arai Y
Jpn J Clin Oncol; 2005 Sep; 35(9):551-8. PubMed ID: 16141296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
